CDHA CAAR

A. “Early and Late Stage Clinical Trials for the Spectrum of Alzheimer’s Disease/Alzheimer’s Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional),” (PAR-23-081, a reissue of PAR-21-359, National Institute on Aging, application deadlines Feb. 5, June 5, and Oct. 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Pilot Studies for the Spectrum of Alzheimer’s Disease/Alzheimer’s Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional),” (PAR-23-083).

grants.nih.gov/grants/guide/pa-files/PAR-23-081.html

B. “Understanding the Supply of Professional Dementia Care Providers and Their Decisions (U54 Clinical Trial Not Allowed),” (RFA-AG-24-024, National Institute on Aging, application deadline February 3, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-24-024.html

C. “Small Grants to Enhance the Use of the All of Us Research Program’s Data (R03 Clinical Trial Not Allowed),” (RFA-PM-23-002, National Institute on Aging, in conjunction with other agencies, application deadline March 1, 2023). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Enhancing the Use of the All of Us Research Programs Data (R21 Clinical Trial Not Allowed),” (RFA-PM-23-001).

grants.nih.gov/grants/guide/rfa-files/RFA-PM-23-002.html

“Alzheimer’s Disease Programs Initiative (ADPI) – State and Community Grant Program (Winter 2023),” (HHS-2023-ACL-AOA-ADPI-0045, February 21, 2023).

www.grants.gov/web/grants/view-opportunity.html?oppId=345029

A. “Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (UG3/UH3 Clinical Trial Required),” (PAR-23-066, a reissue of PAR-22-115, National Institute on Aging, in conjunction with other agencies, application deadline March 17, 2023).

grants.nih.gov/grants/guide/pa-files/PAR-23-066.html

B. “Interorgan Communication in Aging (U01 Clinical Trial Not Allowed),” (RFA-AG-24-005, National Institute on Aging, application deadline June 1, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-24-005.html

C. “Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional),” (RFA-AT-23-009, a reissue of RFA-AT-23-008, National Institute on Aging, in conjunction with other agencies, application deadline January 17, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-AT-23-009.html

D. “HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed),” (RFA-NS-22-022, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 10, 2023, June 9, 2023, Oct. 11, 2023, Feb. 9, 2024, June 11, 2024, Oct. 11, 2024, Feb. 11, 2025). Note: There are three companion funding announcements (follow the link under “Companion Funding Opportunity”): “HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required),” (RFA-NS-22-023); “HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Basic Experimental Studies with Humans Required),” (RFA-NS-22-024); and, “HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed),” (RFA-NS-22-025).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-022.html

“Senior Medicare Patrol State Project Grants,” (HHS-2023-ACL-CIP-MPPG-0006, application deadline February 15, 2023).

www.grants.gov/web/grants/view-opportunity.html?oppId=342836

A. “Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional),” (RFA-AT-23-008, a reissue of RFA-AT-23-006, National Institute on Aging, in conjunction with other agencies, application deadline January 10, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-AT-23-008.html

B. “Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R01 Clinical Trial Optional),” (PAR-23-042, National Institute on Aging, in conjunction with other agencies, application deadline March 9, 2023).

grants.nih.gov/grants/guide/pa-files/PAR-23-042.html

“FY 2023 AmeriCorps Seniors Workforce Development Senior Demonstration Program,” (application deadline February 1, 2022). Note: In addition to information about how to apply, this link also provides access to register for three informational sessions about this Program (Dec. 14, Jan. 4, and Jan. 12).

americorps.gov/funding-opportunity/fy-2023-americorps-seniors-workforce-development-senior-demonstration-program

A. “2023 Innovations in Nutrition Programs and Services -Replication,” (HHS-2023-ACL-AOA-INNU-0008, application deadline January 25, 2023).

www.grants.gov/web/grants/view-opportunity.html?oppId=342842

B. “2023 Innovations in Nutrition Programs and Services -Research,” (HHS-2023-ACL-AOA-INNU-0007, January 25, 2023).

www.grants.gov/web/grants/view-opportunity.html?oppId=342850

“Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional),” (PAR-24-022, a reissue of PAR-20-084, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 16, June 16, and Oct. 16).

grants.nih.gov/grants/guide/pa-files/PAR-24-022.html

“Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed),” (PAR-23-046, a reissue of PAR-20-055, National Institute on Aging, in conjunction with other agencies, application deadline Feb. 5, June. 5, and Oct. 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed),” (PAR-23-047).

grants.nih.gov/grants/guide/pa-files/PAR-23-046.html

A. “2023 Empowering Communities to Deliver and Sustain Evidence-Based Falls Prevention Programs,” (HHS-2023-ACL-AOA-FPSG-0005, application deadline January 11, 2023).

www.grants.gov/web/grants/view-opportunity.html?oppId=342844

B. “2023 Empowering Communities to Deliver and Sustain Evidence-Based Chronic Disease Self-Management Education Programs.” (HHS-2023-ACL-AOA-CSSG-0003, application deadline January 11, 2023).

www.grants.gov/web/grants/view-opportunity.html?oppId=342846

“Disaster Assistance for State Units on Aging (SUAs) and Tribal Organizations in Major Disasters Declared by the President,” (HHS-2023-ACL-AOA-DASG-0002, application deadline Sept. 5, 2023).

www.grants.gov/web/grants/view-opportunity.html?oppId=342838

“Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional),” (RFA-AT-23-006, National Institute on Aging, in conjunction with other agencies, application deadline Jan. 10, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-AT-23-006.html

A. “BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (R34 Clinical Trial Not Allowed),” (RFA-DA-23-030, National Institute on Aging, in conjunction with other agencies, application deadline Feb. 14, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-030.html

B. “The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional),” (RFA-OD-22-028, a reissue of RFA-OD-19-029, National Institute on Aging, in conjunction with other agencies, application deadlines Dec. 19, 2022, Nov. 22, 2023, and Nov. 22, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-028.html

“Funding for 2023-2026 Older Americans Act Title VI Native American Programs,” (HHS-2023-ACL-TITLEVI-2301, application deadline December 6, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=343961

A. “Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Required),” (RFA-AG-23-034, a reissue of RFA-AG-22-016, National Institute on Aging, application deadline January 20, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-034.html

B. “Immunity in Older Adults (U01 Clinical Trial Not Allowed),” (RFA-AI-22-060, National Institute on Aging, in conjunction with other agencies, application deadline Feb. 14, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-AI-22-060.html

C. “BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collaboratory on Human, Non-human Primate, and Mouse Brain Cell Atlases (R01 Clinical Trial Not Allowed),” (RFA-MH-22-292, a reissue of RFA-MH-21-236, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 1, 2023 and Feb. 1, 2024). Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): “BRAIN Initiative Cell Atlas Network (BICAN): Comprehensive Center on Human and Non-human Primate Brain Cell Atlases (UM1 Clinical Trial Not Allowed),” (RFA-MH-22-290); and, “BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) (U24 Clinical Trial Not Allowed),” (RFA-MH-22-291).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-292.html

D. “Advanced Training in Artificial Intelligence for Precision Nutrition Science Research (AIPrN) Institutional Research Training Programs (T32),” (RFA-OD-22-027, National Institute on Aging, in conjunction with other agencies, application deadline Dec. 8, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-027.html

“BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed),” (RFA-DA-23-039, a reissue of RFA-EB-20-002, National Institute on Aging, in conjunction with other agencies, application deadlines Dec. 15, 2022, Sept. 12, 2023, and Sept. 12, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-039.html

A. “HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed),” (RFA-NS-23-006, a reissue of RFA-NS-20-011, National Institute on Aging in conjunction with other ageinces, application deadlines Jan. 4, April 4, and Sept. 4). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed),” (RFA-NS-23-007).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-006.html

B. “HEAL Initiative: Prevention and Management of Chronic Pain in Rural Populations (UG3/UH3, Clinical Trials Required),” (RFA-NR-23-001, National Institute on Aging, application deadline Nov. 21, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-NR-23-001.html

“NIH Blueprint for Neuroscience Research: Computational Training in Neuroscience and Behavior (T90/R90 – Clinical Trial Not Allowed),” (RFA-DA-23-037, National Institute on Aging, in conjunction with other agencies, application deadline November 29, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-037.html

“Understanding the Supply of Professional Dementia Care Providers and Their Decisions (U54 Clinical Trial Not Allowed),” (RFA-AG-23-018, National Institute on Aging, application deadline February 3, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-018.html

A. “Optimization of Genome Editing Therapeutics for Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD) (U01 – Clinical Trials Not Allowed),” (RFA-NS-23-017, National Institute on Aging, in conjunction with other agencies, application deadline Nov. 30, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-017.html

B. “HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed),” (RFA-EB-22-002, National Institute on Aging, in conjunction with other agencies, application deadlines Nov. 14, 2022, June 19, 2023, Feb. 20, 2024, Oct. 15, 2024, June 17, 2025).

grants.nih.gov/grants/guide/rfa-files/RFA-EB-22-002.html

C. “NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed),” (PAR-22-227, a reissue of RFA-AG-22-004, National Institute on Aging, application deadlines Nov. 15, 2022, Oct. 18, 2023, and Oct. 17, 2024). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Independent Clinical Trial Not Allowed),” (PAR-22-226).

grants.nih.gov/grants/guide/pa-files/PAR-22-227.html

“Training Award to Promote Cross-Training in the Fields of Traumatic Brain Injury (TBI) as a Risk Factor for Alzheimer’s Disease/Alzheimer’s Disease Related Dementias (AD/ADRD) (K18 Clinical Trial Not Allowed),” (RFA-NS-22-061, National Institute on Aging, in conjunction with other agencies, application deadline Nov. 4, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-061.html

A. “Alzheimer’s-related Resource Centers for Minority Aging Research (AD/ADRD RCMAR) (P30 Clinical Trial Optional),” (RFA-AG-23-025, a reissue of RFA-AG-18-002, National Institute on Aging, application deadline Oct. 21, 2022). . Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): “Resource Centers for Minority Aging Research (RCMAR) (P30 Clinical Trial Optional),” (RFA-AG-23-026); and, “Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (U24 Clinical Trial Optional),” (RFA-AG-23-027).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-025.html

B. “Early-Stage Therapy Development for ADRD (R61/R33 Clinical Trial Not Allowed),” (RFA-NS-22-059, National Institute on Aging, in conjunction with other agencies, application deadline Oct. 31, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-059.html

C. “HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional),” (RFA-NS-23-003, a reissue of RFA-NS-22-016, National Institute on Aging, in conjunction with other agencies, application deadlines Oct. 10, 2022, June 13, 2023, June 10, 2024, and June 9, 2025).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-003.html

D. “Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional),” (RFA-OD-22-014, a Reissue of RFA-OD-19-013, National Institute on Aging, in conjunction with other agencies, application deadlines September 30, 2022 and August 15, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-014.html

“Geroscience Course (R25 Independent Clinical Trial Not Allowed),” (PAR-22-214, National Institute on Aging, in conjunction with other agencies, application deadline Oct. 21, 2022).

grants.nih.gov/grants/guide/pa-files/PAR-22-214.html

A. “HEAL Initiative: Coordinated Pain Care in Health Care Systems Research Program – Coordinating Center (U24 Clinical Trial Not Allowed),” (RFA-NS-22-065, National Institute on Aging, in conjunction with other agencies, application deadline Nov. 4, 2022). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “NIH HEAL Initiative: Coordinated Approaches to Pain Care in Health Care Systems (UG3/UH3 – Clinical Trial Optional),” (RFA-NS-22-053).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-065.html

B. “Functional Target Validation for Alzheimer’s Disease-Related Dementias (ADRDs) (R61/R33 Clinical Trial Not Allowed),” (RFA-NS-22-055, a reissue of RFA-NS-19-015, National Institute on Aging, in conjunction with other agencies, application deadline Nov. 8, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-055.html

C. “BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional),” (RFA-MH-22-240, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 17, 2023 and Feb. 15, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-240.html

A. “More Monitoring of Cognitive Change, Continued (M3C3) (U2C Clinical Trial Optional),” (RFA-AG-23-021, National Institute on Aging, application deadline Oct. 20, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-021.html

B. “HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL) (R01 Clinical Trial Required),” (RFA-DA-23-041, National Institute on Aging, in conjunction with other agencies, application deadline Sept. 27, 2022). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL): Resource Center (U24- Clinical Trial Optional),” (RFA-DA-23-042).

grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-041.html

C. “BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development (UG3/UH3 Clinical Trial Not Allowed),” (RFA-EB-22-001, National Institute on Aging, in conjunction with other agencies, application due dates Oct. 13, 2022, Oct. 13, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-EB-22-001.html

D. “Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed),” (RFA-OD-22-015, National Institute on Aging, in conjunction with other agencies, application due dates Oct. 27, 2022, Oct. 27, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-015.html

A. “Advancing Research on Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional),” (PAS-22-196, a reissue of PAS-19-316, National Institute on Aging, in conjunction with other agencies, application deadline Jan. 5, April 5, and Sept. 5). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Advancing Research on Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional),” (PAS-22-197).

grants.nih.gov/grants/guide/pa-files/PAS-22-196.html

B. “Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed),” (RFA-AG-23-033, National Institute on Aging, application deadline Oct. 21, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-033.html

A. “Network for Personalization of Diagnostic Tests for Alzheimer’s Disease (AD) and Alzheimer’s Disease-Related Dementias (ADRD) in Older Adults with Multiple Chronic Conditions (MCCs) (U24 Clinical Trial Optional),” (RFA-AG-23-032, National Institute on Aging, application deadline Oct. 17, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-032.html

B. “Pragmatic Clinical Trials in Community Settings to Decrease or Prevent VCID Outcomes, Including in Populations that Experience Health Disparities (U01 Clinical Trial Required),” (RFA-NS-23-001, National Institute on Aging, application deadline Sept. 15, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-23-001.html

“Request for Workshop Proposals – Center for Demography of Health and Aging,” (deadline for application is July 15, 2022). The Center for Demography of Health and Aging invites interested investigators to submit proposals for workshop funding for 2022-2023.

www.ssc.wisc.edu/cdha/cinfo/CDHA workshop-solicitation-6.13.22.docx

“Measures and Methods for Research on Family Caregivers for People Living with Alzheimer’s Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Not Allowed),” (RFA-AG-23-022, National Institute on Aging, application deadline Oct. 20, 2022). Note: There is a companion funding announcement (follow the link under “Companion Funding Opportunity”): “Measures and Methods for Research on Family Caregivers for People Living with Alzheimer’s Disease and Related Dementias (AD/ADRD) (R21 Clinical Trial Not Allowed),” (RFA-AG-23-023).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-022.html

“Disaster Assistance for State Units on Aging (SUAs) and Tribal Organizations in Major Disasters Declared by the President,” (HHS-2022-ACL-AOA-DASG-0068, application deadline Sept. 6, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=335690

“PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed),” (PA-22-176, a reissue of PA-21-259, National Institute on Aging, in conjunction with other agencies, application deadlines Sept. 5, 2022, Jan. 5, 2022, and April 5, 2023). Note: There are three companion funding announcements (follow the link under “Companion Funding Opportunity”): “PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required),” (PA-22-177); “PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed),” (PA-22-178); and, “PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required),” (PA-22-179).

grants.nih.gov/grants/guide/pa-files/PA-22-176.html

“Treatments for Lewy Body Dementias and Frontotemporal Dementias–Exploratory Clinical Trial (U01 Clinical Trial Required),” (RFA-NS-22-056, National Institute on Aging, in conjunction with other agencies, application deadline November 21, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-056.html

“Dissemination and Implementation Research in Health (R01 Clinical Trial Optional),” (PAR-22-105, a reissue of PAR-19-274, National Institute on Aging, in conjunction with other agencies, application deadline Feb. 5, Jun. 5, and Oct. 5). Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): “Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed),” (PAR-22-106); “Dissemination and Implementation Research in Health (R21 Clinical Trial Optional),” (PAR-22-109).

grants.nih.gov/grants/guide/pa-files/PAR-22-105.html

“Supporting State and Community Innovations in Dementia-Specific Respite Programs and Services,” (HHS-2022-ACL-AOA-ADPI-0087, application deadline June 27, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=339599

“Grants for Early Medical/Surgical Specialists Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional),” (RFA-AG-23-031, National Institute on Aging, application deadline Oct. 17, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-031.html

“Native American Elder Justice Initiative,” (HHS-2022-ACL-AOA-IERC-0070, application deadline June 21, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=337806

“Lifespan Respite Care Program: Grants to New States and States Re-Establishing Their Core Respite Infrastructures,” (HHS-2022-ACL-AOA-LRLR-0050, application deadline June 17, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=335011

A. “Demonstration Projects to Promote Use of Interoperable Health Records in Clinical Research (R01 Clinical Trial Not Allowed),” (RFA-AG-23-019, National Institute on Aging, application deadline Oct. 18, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-019.html

B. “Neuronal Vulnerability to Proteinopathies in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (R01 Clinical Trial Not Allowed),” (RFA-AG-23-028, National Institute on Aging, application deadline July 15, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-028.html

“Tribal Long Term Service and Support Resource Center,” (HHS-2022-ACL-AOA-IELT-0069, application deadline April 27, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=337233

“Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed),” (RFA-AG-23-016, a reissue of RFA-AG-22-026, National Institute on Aging, application deadlines Oct. 21, 2022, Oct. 20, 2023, and Oct. 18, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-016.html

A. “Elder Justice Innovation Grants – Enhancing APS Approaches to Cases Involving Opioids and Substance Use Disorders FY2022 ,” (HHS-2022-ACL-AOA-EJIG-0072, application deadline May 3, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=337805

B. “Elder Justice Innovation Grants – Improving Guardianship FY2022,” (HHS-2022-ACL-AOA-EJIG-0071, application deadline May 6, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=337804

C. “Alzheimer’s Disease Programs Initiative (ADPI) – States and Community Grants,” (HHS-2022-ACL-AOA-ADPI-0059, application deadline May 24, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=335000

D. “Legal Assistance Enhancement Program,” (HHS-2022-ACL-AOA-LAEP-0054, application deadline May 3, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=335225

E. “Elder Justice Innovation Grants – Improving Results for APS Clients FY2022,” (HHS-2022-ACL-AOA-EJIG-0055, application deadline May 6, 2022).

www.grants.gov/web/grants/view-opportunity.html?oppId=335067

A. “INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed),” (RFA-OD-22-007, a reissue of RFA-OD-20-004, National Institute on Aging, in conjunction with other agencies, application deadline July 1, 2022, June 30, 2023, and July 1, 2024). Note: There are two companion funding announcements (follow the link under “Companion Funding Opportunity”): “Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed),” (RFA-OD-22-009); “Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required),” (RFA-OD-22-010).

grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-007.html

B. “Emergency Award: Rapid Acceleration of Diagnostics Tribal Data Repository (RADx TDR) (U24 Clinical Trial Not Allowed),” (RFA-OD-22-011, National Institute on Aging, in conjunction with other agencies, application deadline May 31, 2022).

grants.nih.gov/grants/guide/rfa-files/RFA-OD-22-011.html

A. “Implementation Research to Reduce Noncommunicable Disease (NCD) Burden in Low- and Middle-Income Countries (LMICs) and Tribal Nations During Critical Life Stages and Key Transition Periods (R01 Clinical Trial Optional),” .(PAR-22-132, National Institute on Aging, in conjunction with other agencies, application deadline July 27, 2022).

grants.nih.gov/grants/guide/pa-files/PAR-22-132.html

B. “Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional),” (PAR-22-145, a 4eissue of PAR-19-093, National Institute on Aging, in conjunction with other agencies, application deadline Feb. 5, June 5, and Oct. 5).

grants.nih.gov/grants/guide/pa-files/PAR-22-145.html

A. “Focused Technology Research and Development (R01 Clinical Trial Not Allowed),” (PAR-22-127, a reissue of PAR-19-253, National Institute on Aging, in conjunction with other agencies, application deadlines Feb. 5, June 5, and . Oct. 5). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Technology Development Research for Establishing Feasibility and Proof of Concept (R21 – Clinical Trial Not Allowed),” (PAR-22-126).

grants.nih.gov/grants/guide/pa-files/PAR-22-127.html

B. “BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed),” (RFA-MH-22-220, a reissue of of RFA-MH-21-135, National Institute on Aging, in conjunction with other agencies, application deadlines June 10, 2022, Oct. 14, 2022, June 9, 2023, Oct. 13, 2022, June 7, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-MH-22-220.html

A. “NIA Program Project Applications (P01 Clinical Trial Optional),” (PAR-22-130, a reissue of PAR-19-314, National Institute on Aging, application deadlines Jan. 25, May 25, and Sept. 25).
grants.nih.gov/grants/guide/pa-files/PAR-22-130.html

B. “Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional),” (PAR-22-104, a reissue of PAR-21-230, National Institute on Aging, in conjunction with other agencies, application deadline July 13, 2022, July 13, 2023, and July 15, 2024).

grants.nih.gov/grants/guide/pa-files/PAR-22-104.html

C. “Bioengineering Partnerships with Industry (U01 Clinical Trial Optional),” (PAR-22-123, National Institute on Aging, in conjunction with other agencies, application deadlines May 26 and Sept. 26).

grants.nih.gov/grants/guide/pa-files/PAR-22-123.html

“Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (UG3/UH3 Clinical Trial Optional),” (PAR-22-115, National Institute on Aging, in conjunction with other agencies, application deadline April 22, 2022). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Coordinating Center to Support Research on Community Level Interventions for Firearm and Related Violence, Injury and Mortality Prevention (CLIF-VP) (U24 Clinical Trial Not Allowed),” (PAR-22-120).

grants.nih.gov/grants/guide/pa-files/PAR-22-115.html

A. “Noncoding RNAs in Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed),” (RFA-AG-23-010, National Institute on Aging, application deadline July 15, 2022). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Noncoding RNAs in Alzheimer’s Disease and Related Dementias (R21 Clinical Trial Not Allowed),” (RFA-AG-23-011).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-23-011.html

B. “BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs – eTeamBCP (U01 Clinical Trials Optional),” (RFA-NS-22-028, a reissue of RFA-NS-20-029, National Institute on Aging, in conjunction with other agencies, application deadline Jun. 14, 2022, June 15, 2023, and June 14, 2024).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-028.html

A. “BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed),” (RFA-NS-22-026, a reissue of RFA-NS-21-013, National Institute on Aging, in conjunction with other agencies, application deadlines Jul. 1, 2022, Oct. 6, 2022, June 30, 2023, Oct. 4, 2023, June 28, 2024, and Oct. 2, 2024). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed),” (RFA-NS-22-027).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-026.html

B. “HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional),” (RFA-NS-22-050, National Institute on Aging, in conjunction with other agencies, application deadlines March 11, 2022, June 23, 2022, Oct. 13, 2022, and Feb. 23, 2023).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-050.html

“Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional),” (PAR-22-097, a reissue of PAR-21-311, National Institute on Aging, in conjunction with other agencies, application deadlines Nov. 15, 2022, Nov. 15, 2023, and Nov. 15, 2024). Note: There is a companion funding announcements (follow the link under “Companion Funding Opportunity”): “Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)” (PAR-22-098).

grants.nih.gov/grants/guide/pa-files/PAR-22-097.html

A. “NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U24 Clinical Trial Not Allowed),” (PAR-22-110, National Institute on Aging, renewal deadlines May 25 and Sept. 25).

grants.nih.gov/grants/guide/pa-files/PAR-22-110.html

B. “HEAL Initiative: Discovery and Functional Evaluation of Human Pain-associated Genes and Cells (U19 Clinical Trial Not Allowed),” (RFA-NS-22-018, National Institute on Aging, in conjunction with other agencies, application deadlines March 17, 2022, July 7, 2022, Oct. 11, 2022, and March 9, 2023). Note: There is a companion funding announcements (follow the link under ‘Companion Funding Opportunity”): “HEAL Initiative: Human Pain-associated Genes and Cells Data Coordination and Integration Center (U24 Clinical Trial Not Allowed),” (RFA-NS-22-021).

grants.nih.gov/grants/guide/rfa-files/RFA-NS-22-018.html